Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-25-007837
Filing Date
2025-02-25
Accepted
2025-02-25 17:14:25
Documents
5
Effectiveness Date
2025-02-25

Document Format Files

Seq Description Document Type Size
1 S-8 ginkgo-sx82025evergreen.htm S-8 77914
2 EX-FILING FEES ginkgo-sx8filingfeetable20.htm EX-FILING FEES 40845
3 EX-5.1 ginkgos-8x51opinion2025eve.htm EX-5.1 9912
4 EX-23.1 deloitteconsent-sx8.htm EX-23.1 2385
5 EX-23.2 eyconsent-sx8.htm EX-23.2 2554
  Complete submission text file 0001628280-25-007837.txt   134906
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285235 | Film No.: 25664830
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)